Decongestant use during pregnancy and its association with preterm delivery

✍ Scribed by Rohini K. Hernandez; Allen A. Mitchell; Martha M. Werler

• Publisher: John Wiley and Sons
• Year: 2010
• Tongue: English
• Weight: 91 KB
• Volume: 88
• Category: Article
• ISSN: 1542-0752
• DOI: 10.1002/bdra.20699

✦ Synopsis

Abstract

BACKGROUND

Despite the frequent intake of decongestants during pregnancy, only one study to date has evaluated the association of decongestants with preterm delivery, and it identified a reduced risk. We examined this association in more detail.

METHODS

Using a population‐based random sample of 3271 Massachusetts live‐born births without major malformations, we categorized decongestant exposure according to timing, frequency of use, route, and indication. Preterm birth was defined as a gestational age of <37 completed weeks. We estimated hazard ratios and examined confounding by indication by examining various strata of women and through multivariate adjustment.

RESULTS

Compared to nonexposed women, those who took decongestants during the second or third trimester only were less likely to experience preterm delivery (HR, 0.42; 95% CI, 0.21–0.84). This association was observed only for women without preeclampsia.

CONCLUSIONS

A protective association between decongestant use and preterm delivery has now been observed in two studies; however, the possibility of confounding by underlying condition remains. Birth Defects Research (Part A), 2010. © 2010 Wiley‐Liss, Inc.